InMed PharmaceuticalsINM 
$0.38-4.27%24h
-4.27%24h
Global rank35854
Market cap$932.86K
Change 7d-47.30%
YTD Performance-4.75%
SP500 benchmarkUnderperform
P/E-0.12
P/S0.23
Revenue$4.14M
Earnings-$7.95M
Dividend yield-
Main Sector
Healthcare
InMed Pharmaceuticals INM Total Debt
INM Total Debt in 2022: $15.99K
According to InMed Pharmaceuticals latest financial reports the total debt is $15.99K, an decrease of -95.89% to 2022. At the end of 2022 company had $389.50K total debt. This figure represents the debts and financial obligations that InMed Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
InMed Pharmaceuticals INM Total Debt History from 2023 to 2022
-
Value:-
INM Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $15.99K | -95.89% |
| 2022 | $389.50K | 105.77% |
| 2021 | $189.29K | 2.31% |
| 2020 | $185.01K | - |
View the Top Total Debt Stocks 
